Back to search

United Kingdom· GB-APID-26596011000001104

Vibativ 250mg powder for solution for infusion vials

A telavancin product containing telavancin, registered in United Kingdom by Clinigen Healthcare Ltd. The same ATC class is registered in 4 of our 19 countries.

ATC J01XA03

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedVibativ 250mg powder for solution for…ATCJ01XA03REGISTER NO.GB-APID-2659601100000…PACKS LISTED1CHECKEDSeptember 13, 2026

Where it is registered

Telavancin is registered in 4 of 19 countries.

Countries holding a registration under ATC J01XA03 (telavancin), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 3 of them publish a price we can compare per daily dose

Telavancin · ATC J01XA03

4 / 19 countries

  • Belgiumprice
  • Finlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Telavancin
Manufacturer
Clinigen Healthcare Ltd
Country
United Kingdom (GB)
ATC code
J01XA03
ATC class
Telavancin
Defined daily dose
0.7 g, P
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5060229220547

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

185 interactions on record for telavancin.

Graded by severity as the source publishes them — 58 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Telavancin · interactions on record

185 records

  • 58 severe
  • 125 moderate
  • 2 minor

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • HeparinB01AB01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b7efa630-c2e5-4813-bd45-4ea5fd76f93b
GET /v1/drugs/b7efa630-c2e5-4813-bd45-4ea5fd76f93b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "26596011000001104",
  "desc": "Vibativ 250mg powder for solution for infusion vials (Clinigen Healthcare Ltd)",
  "form": "Powder for solution for infusion",
  "vpid": "41882311000001101",
  "source": "dmd",
  "vtm_id": "777693006",
  "strength": "250 mg",
  "substance": "Telavancin",
  "ingredient": "Telavancin hydrochloride",
  "supplier_code": "17974311000001106"
}

See everything about telavancin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.